Gland Pharma Ltd (GLAND) Stock Price & News

GLAND:NSE

Gland Pharma Ltd

₹3,141.60

-0.55%

(-17.30) 1D

Nov 4, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Next call in 37:56:13

Fri, Nov 6, 8:00 AM

Fiscal period

Q2 2027

- / ₹16.87

Revenue / Est. (INR)

- / 17.60B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	14.87B	16.95B	17.43B	18.00B
Cost of goods sold	6.04B	6.31B	8.32B	6.80B
Cost of revenue	6.04B	6.31B	8.32B	6.80B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.85B	4.24B	4.26B	4.44B
Operating expense	6.75B	7.37B	5.22B	7.42B
Total operating expenses	12.79B	13.68B	13.54B	14.22B
Operating income	2.08B	3.27B	3.89B	3.78B
Other non operating income	841.62M	631.73M	-1.79B	612.28M
EBT including unusual items	2.84B	3.62B	5.06B	4.35B
EBT excluding unusual items	2.84B	3.86B	5.02B	4.35B
Income tax expense	1.00B	1.01B	1.39B	1.18B
Effective tax rate	35.30%	27.79%	27.51%	27.13%
Other operating expenses	1.84B	2.06B	-130.22M	1.87B
Net income	1.84B	2.61B	3.67B	3.17B
Net profit margin	12.35%	15.42%	21.04%	17.61%
Earnings per share	11.15	16.98	22.23	19.22
Interest and investment income	-	-	2.06B	-
Interest expense	-78.23M	-39.30M	-63.09M	-43.61M
Net interest expenses	-78.23M	-39.30M	1.99B	-43.61M
Depreciation and amortization charges	1.06B	1.08B	1.09B	1.11B
EBITDA	3.11B	4.17B	4.91B	4.80B
Gain or loss from assets sale	-	-	-	-

Finance